CL Elbon, DB Jacoby and AD Fryer
Department of Environmental Health Sciences, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland 21205.

Inhalational challenge with antigen decreases the function of inhibitory M2 muscarinic autoreceptors on parasympathetic nerves in the lung, increasing the release of acetylcholine from the vagus nerves and potentiating vagally induced bronchoconstriction. It is possible that eosinophils cause M2 receptor dysfunction, perhaps by releasing positively charged proteins that are M2 receptor antagonists. Because of the probable role of interleukin-5 in initiating and maintaining the eosinophil infiltration, we tested the function of neuronal M2 receptors in antigen-challenged guinea pigs after pretreatment with a monoclonal antibody to interleukin-5 (TRFK-5). Ovalbumin was given intraperitoneally to sensitize the animals. Three weeks later, the animals were injected intraperitoneally with either TRFK-5 (240 micrograms/kg i.p.) or saline. Beginning three days later, they were challenged with an ovalbumin aerosol for 5 min on each of four consecutive days. M2 receptor function was tested 24 h after the last antigen challenge. Electrical stimulation of both vagi caused bronchoconstriction and bradycardia. In control animals, pilocarpine attenuated, and gallamine potentiated, vagally induced bronchoconstriction by stimulating and blocking neuronal M2 muscarinic receptors, respectively. In challenged animals that did not receive TRFK-5, these effects were markedly reduced, confirming M2 receptor dysfunction. In TRFK-5-treated guinea pigs, the effects of both pilocarpine and gallamine were the same as those in control animals, demonstrating normal M2 receptor function. Pretreatment with TRFK-5 selectively inhibited the migration of eosinophils into the lungs as measured by lung lavage. Thus the function of M2 muscarinic receptors in antigen-challenged guinea pigs can be protected by inhibiting eosinophil influx into the lungs.

This article has been cited by other articles:

				N. G. Verbout, J. K. Lorton, D. B. Jacoby, and A. D. Fryer Atropine pretreatment enhances airway hyperreactivity in antigen-challenged guinea pigs through an eosinophil-dependent mechanism Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1126 - L1135. [Abstract] [Full Text] [PDF]

				N. Durcan, R. W. Costello, W. G. McLean, J. Blusztajn, B. Madziar, A. G. Fenech, I. P. Hall, G. J. Gleich, L. McGarvey, and M.-T. Walsh Eosinophil-Mediated Cholinergic Nerve Remodeling Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 775 - 786. [Abstract] [Full Text] [PDF]

				K. E. Belmonte Cholinergic Pathways in the Lungs and Anticholinergic Therapy for Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 297 - 304. [Abstract] [Full Text] [PDF]

				B. J. Proskocil and A. D. Fryer {beta}2-Agonist and Anticholinergic Drugs in the Treatment of Lung Disease Proceedings of the ATS, November 1, 2005; 2(4): 305 - 310. [Abstract] [Full Text] [PDF]

				B. L. Yost, G. J. Gleich, D. B. Jacoby, and A. D. Fryer The changing role of eosinophils in long-term hyperreactivity following a single ozone exposure Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L627 - L635. [Abstract] [Full Text] [PDF]

				D. A. Sawatzky, P. J. Kingham, N. Durcan, W. G. McLean, and R. W. Costello Eosinophil-induced release of acetylcholine from differentiated cholinergic nerve cells Am J Physiol Lung Cell Mol Physiol, December 1, 2003; 285(6): L1296 - L1304. [Abstract] [Full Text] [PDF]

				D. Shusterman Individual Factors in Nasal Chemesthesis Chem Senses, July 1, 2002; 27(6): 551 - 564. [Abstract] [Full Text] [PDF]

				C. M. EVANS, D. B. JACOBY, and A. D. FRYER Effects of Dexamethasone on Antigen-Induced Airway Eosinophilia and M2 Receptor Dysfunction Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1484 - 1492. [Abstract] [Full Text]

				C. M. Evans, K. E. Belmonte, R. W. Costello, D. B. Jacoby, G. J. Gleich, and A. D. Fryer Substance P-induced airway hyperreactivity is mediated by neuronal M2 receptor dysfunction Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L477 - L486. [Abstract] [Full Text] [PDF]

				D. B. Jacoby, B. L. Yost, T. Elwood, and A. D. Fryer Effects of neurokinin receptor antagonists in virus-infected airways Am J Physiol Lung Cell Mol Physiol, July 1, 2000; 279(1): L59 - L65. [Abstract] [Full Text] [PDF]

				D. J. Adamko, B. L. Yost, G. J. Gleich, A. D. Fryer, and D. B. Jacoby Ovalbumin Sensitization Changes the Inflammatory Response to Subsequent Parainfluenza Infection: Eosinophils Mediate Airway Hyperresponsiveness, M2 Muscarinic Receptor Dysfunction, and Antiviral Effects J. Exp. Med., November 15, 1999; 190(10): 1465 - 1478. [Abstract] [Full Text] [PDF]

				T. Casale Immunobiology of Asthma and Rhinitis . Pathogenic Factors and Therapeutic Options Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1778 - 1787. [Full Text]

				B. L. Yost, G. J. Gleich, and A. D. Fryer Ozone-induced hyperresponsiveness and blockade of M2 muscarinic receptors by eosinophil major basic protein J Appl Physiol, October 1, 1999; 87(4): 1272 - 1278. [Abstract] [Full Text] [PDF]

				R. W. Costello, C. M. Evans, B. L. Yost, K. E. Belmonte, G. J. Gleich, D. B. Jacoby, and A. D. Fryer Antigen-induced hyperreactivity to histamine: role of the vagus nerves and eosinophils Am J Physiol Lung Cell Mol Physiol, May 1, 1999; 276(5): L709 - L714. [Abstract] [Full Text] [PDF]

				K. E. Belmonte, A. D. Fryer, and R. W. Costello Role of insulin in antigen-induced airway eosinophilia and neuronal M2 muscarinic receptor dysfunction J Appl Physiol, November 1, 1998; 85(5): 1708 - 1718. [Abstract] [Full Text] [PDF]

				A. D. FRYER and D. B. JACOBY Muscarinic Receptors and Control of Airway Smooth Muscle Am. J. Respir. Crit. Care Med., November 1, 1998; 158(2007): S154 - S160. [Abstract] [Full Text] [PDF]

				R W Costello, D B Jacoby, and A D Fryer Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity Thorax, July 1, 1998; 53(7): 613 - 618. [Full Text]

				S. Okada, J. B. Hagan, M. Kato, J. L. Bankers-Fulbright, L. W. Hunt, G. J. Gleich, and H. Kita Lidocaine and its Analogues Inhibit IL-5-Mediated Survival and Activation of Human Eosinophils J. Immunol., April 15, 1998; 160(8): 4010 - 4017. [Abstract] [Full Text] [PDF]

				L. J. Janssen, I. McGrogan, J. Wattie, P. M. O'Byrne, and E. E. Daniel Myogenic and neurogenic mechanisms and arachidonate metabolites in bronchial muscle response to allergen Am J Physiol Lung Cell Mol Physiol, December 1, 1997; 273(6): L1118 - L1125. [Abstract] [Full Text] [PDF]

				B. B. VARGAFTIG Modifications of Experimental Bronchopulmonary Hyperresponsiveness Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): S97 - S102. [Abstract] [Full Text] [PDF]

				A. Fryer, Y.-C. Huang, G. Rao, D. Jacoby, E. Mancilla, R. Whorton, C. A. Piantadosi, T. Kennedy, and J. Hoidal Selective O-Desulfation Produces Nonanticoagulant Heparin that Retains Pharmacological Activity in the Lung, J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 208 - 219. [Abstract] [Full Text]

				A. D. KRANEVELD, F. P. NIJKAMP, and A. J. M. VAN OOSTERHOUT Role for Neurokinin-2 Receptor in Interleukin-5-induced Airway Hyperresponsiveness but not Eosinophilia in Guinea Pigs Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 367 - 374. [Abstract] [Full Text]

				D. A. Sawatzky, P. J. Kingham, E. Court, B. Kumaravel, A. D. Fryer, D. B. Jacoby, W. G. McLean, and R. W. Costello Eosinophil adhesion to cholinergic nerves via ICAM-1 and VCAM-1 and associated eosinophil degranulation Am J Physiol Lung Cell Mol Physiol, June 1, 2002; 282(6): L1279 - L1288. [Abstract] [Full Text] [PDF]